Insights from BioCina
From process development to commercial manufacturing, learn more through our library of resources provided by our team of industry experts.
Featured Resource
About BioCina
Learn about BioCina’s superior FDA and cGMP approved manufacturing development and manufacturing services.
Australia as a Strategic Gateway: The Economic and Regulatory Advantages of Clinical Manufacturing Down Under
Biopharmaceutical companies are under mounting pressure to move faster, spend less, and ensure global compliance all without compromising innovation. This is especially true in clinical-stage manufacturing, where timelines and capital efficiency are everything.
Biopharmaceutical companies are under mounting pressure to move faster, spend less, and ensure global compliance all without compromising innovation. This is especially true in clinical-stage manufacturing, where timelines and capital efficiency are everything.
In this new expert-authored article, BioCina explores why Australia is emerging as a global hub for biomanufacturing and how sponsors can benefit from its combination of tax rebates, regulatory efficiency, and advanced biopharma infrastructure.
Highlights include:
- Australia’s 48.5% tax incentive and how it substantially lowers clinical costs
- Regulatory pathways that eliminate IND requirements and reduce start-up time
- How BioCina’s Adelaide and Perth facilities enable seamless development for microbial, pDNA, LNP and mRNA programs, from drug substance through fill–finish
- The role of Australia’s national clinical trial network and digital health infrastructure in supporting faster, more efficient programs
With decades of operational excellence and Big Pharma heritage, BioCina is helping global clients turn Australia into a launchpad for clinical and commercial success.
Access the article here:
The Six Keys to Client Satisfaction in Biologics CDMO Services
This article explores the significant opportunities within the biologics contract development and manufacturing organisation (CDMO) industry to optimise client satisfaction by meeting the critical demands of discerning clients. Six key facets are identified as pivotal to success, while underscoring the fundamental role of a client-centric approach and the importance of building and nurturing strong client relationships.
Credit: Innovations in Pharmaceutical Technology, Spring 2024, pages 22-24. © Samedan Ltd.
Leveraging Australia’s Biopharma Benefits
Australia is quickly becoming the fastest and most cost-efficient destination for biopharma R&D, clinical trials, and commercialization. Here, we describe how to leverage Australia’s biopharma benefits to get therapeutics to market faster and more affordably.